Clinical Trial Update: Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating febuxostat for prevention of tumor lysis syndrome in pediatric and adult patients with hematological malignancies; study terminated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumor Lysis Syndrome

Drugs mentioned

• FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Menarini Group | Conditions: Tumor Lysis Syndrome | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-06-03